Insight Molecular Diagnostics Inc. (IMDX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 800K 1.6M 2.4M Q3 '24: 115K Q4 '24: 1.5M Q1 '25: 2.1M Q2 '25: 518K Q3 '25: 260K Q4 '25: 1.1M Q1 '26: 32K Q2 '26: 239K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 500K 1M 1.5M Q3 '24: 50K Q4 '24: 595K Q1 '25: 1.3M Q2 '25: 338K Q3 '25: 139K Q4 '25: 496K Q1 '26: 15K Q2 '26: 157K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -13.5M Q4 '24: -33.6M Q1 '25: -6.8M Q2 '25: -9.8M Q3 '25: -11M Q4 '25: -23.4M Q1 '26: -4.4M Q2 '26: -11.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -13.5M Q4 '24: -33.5M Q1 '25: -6.7M Q2 '25: -9.7M Q3 '25: -10.9M Q4 '25: -23M Q1 '26: -4.3M Q2 '26: -11.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 300K 600K 900K Q3 '24: 43K Q4 '24: 869K Q1 '25: 813K Q2 '25: 180K Q3 '25: 121K Q4 '25: 643K Q1 '26: 17K Q2 '26: 82K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -5.5M Q4 '24: -5.4M Q1 '25: -5.8M Q2 '25: -6.2M Q3 '25: -4.6M Q4 '25: -5.5M Q1 '26: -7.6M Q2 '26: -9.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -5.6M Q4 '24: -5.6M Q1 '25: -6.1M Q2 '25: -6.5M Q3 '25: -5.7M Q4 '25: -7M Q1 '26: -8.3M Q2 '26: -10M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '24: 8.3M Q2 '24: 12.9M Q3 '24: 13.7M Q1 '25: 25.7M Q2 '25: 32M Q3 '25: 32M Q1 '26: 34.5M Q2 '26: 36.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '24: -4.54 Q4 '24: -4.77 Q1 '25: -3.90 Q2 '25: -3.84 Q3 '25: -3.20 Q4 '25: -1.64 Q1 '26: -1.50 Q2 '26: -1.51 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.